Evidence map›Paper›PMID 31860135›Full record

ArticleCancer2020

Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.

Jeanne S Mandelblatt, Wanting Zhai, Jaeil Ahn, Brent J Small, Tim A Ahles, Judith E Carroll, Neelima Denduluri, Asma Dilawari, Martine Extermann, Deena Graham and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Effect of the Fit2Thrive Intervention on Patient-reported Outcomes in Breast Cancer Survivors: A Randomized Full Factorial Trial.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2023
    Trial
  7. Article
  8. Article
  9. Survivorship Issues in Older Adults with Breast Cancer.Current breast cancer reports · 2025
    Article
  10. Article
  11. Core preoperative symptoms and patients' symptom experiences in oral cancer: a mixed-methods study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Article
  13. Predictive risk model of mild cognitive impairment in patients with malignant haematological diseases after haematopoietic stem cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  19. Article
  20. Acute cancer-related symptoms and concerns among patients receiving chemotherapy: current state of the science.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jeanne S MandelblattDepartment of Oncology, Georgetown University, Washington, DC.ORCID 0000-0002-2490-005X
Wanting ZhaiDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC.
Jaeil AhnDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC.
Brent J SmallSchool of Aging Studies, University of South Florida, and Senior Member, H. Lee Moffitt Cancer Center, Tampa, Florida.
Tim A AhlesDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York.
Judith E CarrollDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, California.ORCID 0000-0001-5516-0819
Neelima DenduluriVirginia Cancer Specialists, US Oncology, Arlington, Virginia.ORCID 0000-0002-6075-6809
Asma DilawariDepartment of Medicine, Georgetown University, Washington, DC.
Martine ExtermannDepartment of Medicine, H. Lee Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0003-4381-1199
Deena GrahamJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.
Arti HurriaDepartment of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.ORCID 0000-0001-7983-9615
Claudine IsaacsDepartment of Oncology, Georgetown University, Washington, DC.
Paul B JacobsenHealthcare Delivery Research Program, National Cancer Institute, Bethesda, Maryland.
Heather S L JimHealth Outcomes and Behavior Department, H. Lee Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0001-7353-3711
George LutaDepartment of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.ORCID 0000-0002-4035-7632
Brenna C McDonaldDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana.
Sunita K PatelDepartment of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California.ORCID 0000-0002-9023-8391
James C RootDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, California.
Andrew J SaykinDepartment of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana.
Danielle B TometichDepartment of Psychology, Indiana University-Purdue University Indianapolis, Indiana.
Xingtao ZhouDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC.ORCID 0000-0002-5164-125X
Harvey J CohenJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Training and Career Development CoreU54CA132378 · NCI · CITY COLLEGE OF NEW YORK · PI Tim Alan Ahles, ADRIANA ESPINOSA · 2008 to 2026
$28.9M
Training and Career Development and Education CoreU54CA137788 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ADRIANA ESPINOSA, FRANCESCA M GANY · 2008 to 2026
$28.1M
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINER01CA129769 · NCI · GEORGETOWN UNIVERSITY · PI AHLES, TIM ALAN, MANDELBLATT, JEANNE · 2009 to 2020
$7.3M
Bio-behavioral Research At The Intersection of Cancer and AgingR35CA197289 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2015 to 2021
$6.2M
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the MicrobiomeR01CA219389 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2018 to 2022
$3.5M
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & SmokingR01CA172119 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AHLES, TIM ALAN, HURRIA, ARTI · 2013 to 2017
$3.5M
Randomized Placebo Controlled Trial of Bupropion for Cancer Related FatigueR01CA214647 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2018 to 2022
$3.0M
Sickness Behaviors in Gynecologic Cancer Patients Treated with ChemotherapyR01CA164109 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI JIM, HEATHER S.L. · 2012 to 2016
$2.5M
Interdisciplinary Training in Cancer Prevention and ControlT32CA117865 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI Victoria Lee Champion, Catherine E Mosher · 2016 to 2026
$2.4M
A prospective examination of change in executive function and physical activity in older breast cancer survivors.F31CA220964 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI TOMETICH, DANIELLE · 2018 to 2019
$44k
EPA EP-C-17-023EPA EP-D-17-023NCI NIH HHS F31 CA220964NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA129769NCI NIH HHS R01 CA164109NCI NIH HHS R01 CA172119NCI NIH HHS R01 CA214647NCI NIH HHS R01 CA219389NCI NIH HHS R35 CA197289NCI NIH HHS T32 CA117865NCI NIH HHS U54 CA132378NCI NIH HHS U54 CA137788
6 · The paper itself

Abstract

backgroundLittle is known about longitudinal symptom burden, its consequences for well-being, and whether lifestyle moderates the burden in older survivors.

methodsThe authors report on 36-month data from survivors aged ≥60 years with newly diagnosed, nonmetastatic breast cancer and noncancer controls recruited from August 2010 through June 2016. Symptom burden was measured as the sum of self-reported symptoms/diseases as follows: pain (yes or no), fatigue (on the Functional Assessment of Cancer Therapy [FACT]-Fatigue scale), cognitive (on the FACT-Cognitive scale), sleep problems (yes or no), depression (on the Center for Epidemiologic Studies Depression scale), anxiety (on the State-Trait Anxiety Inventory), and cardiac problems and neuropathy (yes or no). Well-being was measured using the FACT-General scale, with scores from 0 to 100. Lifestyle included smoking, alcohol use, body mass index, physical activity, and leisure activities. Mixed models assessed relations between treatment group (chemotherapy with or without hormone therapy, hormone therapy only, and controls) and symptom burden, lifestyle, and covariates. Separate models tested the effects of fluctuations in symptom burden and lifestyle on function.

resultsAll groups reported high baseline symptoms, and levels remained high over time; differences between survivors and controls were most notable for cognitive and sleep problems, anxiety, and neuropathy. The adjusted burden score was highest among chemotherapy-exposed survivors, followed by hormone therapy-exposed survivors versus controls (P < .001). The burden score was related to physical, emotional, and functional well-being (eg, survivors with lower vs higher burden scores had 12.4-point higher physical well-being scores). The composite lifestyle score was not related to symptom burden or well-being, but physical activity was significantly associated with each outcome (P < .005).

conclusionsCancer and its treatments are associated with a higher level of actionable symptoms and greater loss of well-being over time in older breast cancer survivors than in comparable noncancer populations, suggesting the need for surveillance and opportunities for intervention.

Indexed as

Cancer SurvivorsLife StyleSymptom AssessmentAgedAged, 80 and overAntineoplastic AgentsAntineoplastic Agents, HormonalAnxietyBreast NeoplasmsCancer PainCognition DisordersCohort StudiesDepressionExerciseFatigueFemaleAntineoplastic AgentsAntineoplastic Agents, Hormonalbreast cancerolder patientssurvivorshipsymptom burdenwell-being

Identifiers

PMID31860135
PMCPMC7255412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.